Loading...

Bri-Chem Corp.

BRY.TOTSX
Energy
Oil & Gas Equipment & Services
CA$0.28
CA$-0.00(-1.75%)

Bri-Chem Corp. (BRY.TO) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Bri-Chem Corp. (BRY.TO), covering cash flow, earnings, and balance sheets.

Revenue Growth
-21.66%
21.66%
Operating Income Growth
-75.28%
75.28%
Net Income Growth
-523.51%
523.51%
Operating Cash Flow Growth
-18.14%
18.14%
Operating Margin
1.66%
1.66%
Gross Margin
14.55%
14.55%
Net Profit Margin
-3.38%
3.38%
ROE
-13.53%
13.53%
ROIC
5.26%
5.26%

Bri-Chem Corp. (BRY.TO) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Bri-Chem Corp. BRY.TO financial performance.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$19.91M$20.62M$21.98M$19.11M
Cost of Revenue$16.47M$17.91M$18.16M$17.20M
Gross Profit$3.44M$2.71M$3.82M$1.90M
Gross Profit Ratio$0.17$0.13$0.17$0.10
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$2.99M$2.02M$3.28M$1.28M
Operating Expenses$3.32M$2.33M$3.58M$1.28M
Total Costs & Expenses$19.79M$20.24M$21.74M$18.49M
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$725863.00$703644.00$787982.00$896945.00
Depreciation & Amortization$327500.00$313307.00$307310.00$325367.00
EBITDA$466618.00-$1.17M$587164.00$706827.00
EBITDA Ratio$0.02-$0.06$0.03$0.04
Operating Income$121088.00$380452.00$233835.00$620160.00
Operating Income Ratio$0.006$0.02$0.01$0.03
Other Income/Expenses (Net)-$707833.00-$2.57M-$741963.00-$1.14M
Income Before Tax-$586745.00-$2.19M-$508128.00-$515481.00
Income Before Tax Ratio-$0.03-$0.11-$0.02-$0.03
Income Tax Expense-$174965.00-$602374.00-$239301.00-$27680.00
Net Income-$411780.00-$1.59M-$268827.00-$487801.00
Net Income Ratio-$0.02-$0.08-$0.01-$0.03
EPS-$0.02-$0.06-$0.01-$0.02
Diluted EPS-$0.02-$0.06-$0.01-$0.02
Weighted Avg Shares Outstanding$26.43M$26.43M$26.88M$26.43M
Weighted Avg Shares Outstanding (Diluted)$26.53M$26.43M$26.88M$26.43M

Over the past four quarters, Bri-Chem Corp. demonstrated steady revenue growth, increasing from $19.11M in Q2 2024 to $19.91M in Q1 2025. Operating income reached $121088.00 in Q1 2025, maintaining a consistent 1% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $466618.00, reflecting operational efficiency. Net income rose to -$411780.00, with EPS at -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;